Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Antibody, Nanoparticle and Cell-Based Oncology Probes

  • You have access
    PET of follicle-stimulating hormone receptor: Broadly applicable for imaging of cancer
    Hao Hong, Yongjun Yan, Sixiang Shi, Hector Valdovinos, Robert Nickles and Weibo Cai
    Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 275;
  • You have access
    111In-anti-F4/80 for in vivo tracking of tumor associated macrophages
    Samantha Terry, Otto Boerman, Danny Gerrits, Josbert Metselaar, Steffi Lehmann, Christian Gerdes, Wim Oyen and Keelara Abiraj
    Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 274;
  • You have access
    Pretargeted approach for tumor PET imaging using supramolecular nanoparticles with in vivo bioorthogonal chemistry
    Yan Xing, Jin-sil Choi, Jinliang Peng, Wei-Yu Lin, Guoquan Li, Peter Conti, Hsian-Rong Tseng and Kai Chen
    Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 277;
  • You have access
    Generation and use of long-lasting cell labeling agent for positron emission tomography (PET) imaging
    Noriko Sato, Haitao Wu, Gary Griffiths and Peter Choyke
    Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 273;
  • You have access
    Multimodal nanoprobes with pharmacokinetic and radiometal tunablity for SPECT or PET imaging
    Hoonsung Cho, Hushan Yuan, Yanyan Guo and Lee Josephson
    Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 272;
  • You have access
    A new fluorescence/PET probe for intracellular human telomerase reverse transcriptase (hTERT) using Tat peptide-conjugated antibody
    Kyung Oh Jung, Hyewon Youn, Mi Jeong Kim, Keon Wook Kang, Dong Soo Lee and June-Key Chung
    Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 276;
  • You have access
    Preclinical evaluation of anti-αvβ6 diabodies and anti-αvβ6 cys-diabodies for imaging αvβ6-positive tumors with positron emission tomography
    Jason White, David Boucher, Kirstin Zettlitz, Anna Wu and Julie Sutcliffe
    Journal of Nuclear Medicine May 1, 2014, 55 (supplement 1) 271;
SNMMI

© 2025 SNMMI

Powered by HighWire